Church of PeptidesSearch
Survodutide · Chapter 2 of 6

The mouse keeps its own notebook

Animal stage · 2022 discovery paper

What changed in mice—and what stays a mouse finding?

Fictional scene

Subject One draws an enormous arrow from a mouse enclosure to a human silhouette. Doctide erases the arrow. The mouse keeps exploring. Subject One labels two separate notebooks and finally leaves room between them.

What changes here

Mouse weight loss supported further investigation; it did not establish the same effect in people. [1]

Read the study details & dates
Published 2022 · Thirty-day experiment

Diet-induced obese mice

Repeated subcutaneous BI 456906 was compared with vehicle and semaglutide. Weight fell alongside changes in food intake and energy expenditure. Lean mass also declined at some tested regimens. These are preclinical mouse experiments, not human efficacy or muscle-preservation results; no clinical phase or NCT applies. [1]

Dataset public December 9, 2022

A separate research record

The accompanying mouse study deposited molecular-expression data in GEO as GSE211105. Dataset release dates do not identify when every animal experiment began. [2]

What this does not establish

This selected efficacy record is not a complete mortality or toxicology account. No absence of animal deaths, tumors or long-term harm is inferred from incomplete reporting.

Original sources
  1. Zimmermann et al. — discovery and preclinical pharmacology, Molecular Metabolism, 2022
  2. NCBI GEO — original mouse dataset GSE211105

Discovery paper and original dataset checked October 27, 2026. Animal and human evidence remain separate.

Up next
Can glucose and weight improve without ignoring tolerability?

Subject One is fictional. Separate studies, species and populations are not a single patient’s experience. How to read the story